Immuron Director Resignation
MELBOURNE, Australia, May 03, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Stephen Anastasiou has resigned from his position as Non-Executive Director effective today to focus on his other business interests.
- MELBOURNE, Australia, May 03, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Stephen Anastasiou has resigned from his position as Non-Executive Director effective today to focus on his other business interests.
- Stephen has served as a Director since 2013 and has provided valued contributions and experienced counsel to the Company.
- During Stephen’s tenure, Immuron launched Travelan® into the USA and Canadian markets and dual listed the Company on NASDAQ (IMRN).
- I would like to thank him for his support and active contributions.”
This release has been authorised by the directors of Immuron Limited.